Abbott Laboratories (NYSE: ABT) is 16.82% higher on its value in year-to-date trading and has touched a low of $99.71 and a high of $132.65 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ABT stock was last observed hovering at around $130.18 in the last trading session, with the day’s gains setting it 1.95%.
Currently trading at $132.13, the stock is 2.73% and 10.35% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.8 million and changing 1.50% at the moment leaves the stock 17.31% off its SMA200. ABT registered 16.27% gain for a year compared to 6-month gain of 19.04%.
The stock witnessed a 16.43% loss in the last 1 month and extending the period to 3 months gives it a 14.87%, and is 0.52% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.54% over the week and 2.29% over the month.
Abbott Laboratories (ABT) has around 114000 employees, a market worth around $229.17B and $41.95B in sales. Current P/E ratio is 17.24 and Fwd P/E is 23.14. Profit margin for the company is 31.91%. Distance from 52-week low is 32.51% and -0.39% from its 52-week high. The company has generated returns on investments over the last 12 months (25.44%).
The EPS is expected to grow by 10.41% this year
The shares outstanding are 1.73B, and float is at 1.72B with Short Float at 1.06%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 166.35 million shares valued at $17.29 billion. The investor’s holdings represent 9.5932 of the ABT Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 131.13 million shares valued at $13.63 billion to account for 7.5619 of the shares outstanding. The other top investors are STATE STREET CORP which holds 74.4 million shares representing 4.2903 and valued at over $7.73 billion, while CAPITAL INTERNATIONAL INVESTORS holds 4.1405 of the shares totaling 71.8 million with a market value of $7.46 billion.
Abbott Laboratories (ABT) Insider Activity
The most recent transaction is an insider sale by Ford Robert B, the company’s CHAIRMAN AND CEO. SEC filings show that Ford Robert B sold 285,388 shares of the company’s common stock on Feb 05 ’25 at a price of $131.17 per share for a total of $37.44 million. Following the sale, the insider now owns 0.22 million shares.
Still, SEC filings show that on Jan 29 ’25, ALLEN HUBERT L (EXECUTIVE VICE PRESIDENT) disposed off 131,360 shares at an average price of $128.35 for $16.86 million. The insider now directly holds 184,806 shares of Abbott Laboratories (ABT).
